{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:00:01Z","timestamp":1777291201068,"version":"3.51.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"DOI":"10.7759\/cureus.42266","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T17:09:05Z","timestamp":1689959345000},"source":"Crossref","is-referenced-by-count":2,"title":["Spontaneous Development of Immune-Mediated Necrotizing Myopathy (IMNM) After Chronic Use of Statins: A Case Report"],"prefix":"10.7759","author":[{"given":"Michael T","family":"Luong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Danahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald Y","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020, 16:689-701. 10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","unstructured":"UpToDate. Overview of and approach to the idiopathic inflammatory myopathies. (2022). Accessed: March 20, 2023: https:\/\/www.uptodate.com\/contents\/overview-of-and-approach-to-the-idiopathic-inflammatory-myopathies."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0548-6","article-title":"Immune-mediated necrotizing myopathy: update on diagnosis and management","volume":"17","author":"Basharat P","year":"2015","unstructured":"Basharat P, Christopher-Stine L. Immune-mediated necrotizing myopathy: update on diagnosis and management. Curr Rheumatol Rep. 2015, 17:72. 10.1007\/s11926-015-0548-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-021-00174-1","article-title":"Therapeutic management of immune-mediated necrotizing myositis","volume":"7","author":"Weeding E","year":"2021","unstructured":"Weeding E, Tiniakou E. Therapeutic management of immune-mediated necrotizing myositis. Curr Treatm Opt Rheumatol. 2021, 7:150-60. 10.1007\/s40674-021-00174-1","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez I","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018, 20:21. 10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/152391-spontaneous-development-of-immune-mediated-necrotizing-myopathy-imnm-after-chronic-use-of-statins-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:02Z","timestamp":1707508862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/152391-spontaneous-development-of-immune-mediated-necrotizing-myopathy-imnm-after-chronic-use-of-statins-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.42266","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}